Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialPubMed

Modified peri-areolar mastopexy and fat grafting in complex breast ptosis: A randomized open-label controlled trial.

Gentile P.

Randomized Controlled Trial with a reported sample of 35 on Scar, published in J Plast Reconstr Aesthet Surg (2024) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
J Plast Reconstr Aesthet Surg (2024)
Country
Netherlands
Reported sample size
35
Source database
PubMed
PMID
39277967
DOI
10.1016/j.bjps.2024.09.002
Citations
2

Abstract (original English)

Background Complex breast ptosis may be caused by moderate to severe degrees of skin and glandular sagging associated with breast and nipple-areola complex (NAC) asymmetries and deformities. The use of traditional peri-areolar mastopexy (t-PM) with or without implants is limited only to mild or moderate breast ptosis. Objectives This study aimed to report the safety and efficacy of the modified peri-areolar mastopexy (m-PM) characterized by a vertical shift of the classical pattern with implants and fat grafting (FG) in complex breast ptosis and to evaluate the influence of breast and NAC asymmetries, breast, and chest deformities on aesthetics outcomes. Methods An open-label randomized controlled trial was performed. Forty women (study group - SG) affected by breast ptosis (moderate and severe), asymmetries, and deformities were treated with m-PM, implants, and FG, and their outcomes were compared with those in a control group (CG) (n = 35) treated with t-PM and implants. Aesthetic outcomes were evaluated using the patient's satisfaction grade, physician's assessment score, and visual Analog Scale (VAS). Results Overall, 75% (n = 30) of SG patients reported excellent results in terms of breast lift, shape, volume, NAC position, and scar quality after 12 months, whereas the CG reported the same outcomes in 60% (n = 21) of the cases. SG patients showed a vertical NAC shift and a

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
HumansFemaleMammaplastyAdultPatient SatisfactionAdipose TissueMiddle AgedNipplesTreatment OutcomeEsthetics

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research